The researchers at Mount Sinai have found that a simple blood test called liquid biopsy could be a better indicator of whether cancer immunotherapy will be successful for lung cancer patients than…
Tag: Lung Cancer Awareness
Adolescent Smoking and Lung Cancer
Tobacco use and cigarette smoking remains the topmost causes behind occurrence of lung cancer. Also, smoking causes damage to almost every organ of the body including lungs, blood vessels, heart, mouth, skin,…
Imaging Approach to Detect Lung Cancer Earlier, Study Reveals
Lung cancer is the third most common type of cancers in the United States, according to the Cancers for Disease Control and Prevention. A new study has found a new way for…
All You Need to Know About Pediatric Non-Small Cell Lung Cancer
Primary lung cancer is extremely rare in children. Pediatric non-small cell lung cancer (NSCLC) is the term for occurrence of NSCLC in children and adolescents. NSCLC that develops in young people is…
What is Lung Biopsy?
Lung biopsy is a form of medical treatment and there can be a number of reasons for doctors recommending it. Then, there are several types of biopsy and one selects according to…
Personalized Blood Test to Help Selection of Lung Cancer Treatment
University of Cambridge has led a study that showed that a personalized blood test performed after lung cancer treatment could help in detection of patients who are at high risk of return…
FDA Approves FoundationOne CDx in Non-Small Cell Lung Cancer
U.S. Food and Drug Administration (FDA) has approved the FoundationOne CDx as a companion diagnostic to guide treatment selection for patients with non-small cell lung cancer. This approval applies to the use…
FDA Approves Nivolumab Plus Chemo as Neoadjuvant Therapy for NSCLC Treatment
The FDA has approved nivolumab plus platinum-doublet chemotherapy for patients with non-small cell lung cancer in the neoadjuvant setting. Nivolumab is the first immune checkpoint inhibitor to get approval for resectable NSCLC….